Several reports have suggested that highly malignant N-type NB cell lines are resistant to TRAIL-mediated cell death, whereas more differentiated and noninvasive S-type NB cell lines remain susceptible to TRAIL [28–30]. The gene discussed is TNFSF10; the disease is neuroblastoma.